Results 171 to 180 of about 11,406 (228)

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant. [PDF]

ERJ Open Res
Yaacoby-Bianu K, Heching M, Kramer MR, Shmueli E, Prais D, Vermeulen F, Ramalho AS, Cohen R, Livnat G, Shteinberg M.   +9 more
europepmc   +1 more source

Strength-Oriented Virtual Exercise Training Intervention in Children and Adolescents with Cystic Fibrosis Under CFTR Modulators (the FIQMODE Study): Study Protocol for a Randomized Controlled Trial. [PDF]

Curr Protoc
Pantoja-Arévalo L, Yvert T, Iturriaga T, Sanz-Santiago V, Barceló O, Quesada-González C, Morales-Tirado A, Santiago-Dorrego C, López-Neyra A, Ruiz de Valbuena M, De Manuel Gómez C, Rubio Alonso M, De Vidania S, Ramírez-Castillejo C, González-Gross M, Pérez-Ruiz M.   +15 more
europepmc   +1 more source

Clinical Outcomes in Patients with Cystic Fibrosis Receiving CFTR Modulators: A Comparison of Childhood Versus Adolescent Initiation. [PDF]

Children (Basel)
Toraih EA, Malik HA, Islam RK, Pirzadah HA, Abdelmaksoud A, Elshazli RM, Boasiako PA, Alenazi SA, Dabel A, Jishu JA, Alenezi BT, Aiash H, Fawzy MS.   +12 more
europepmc   +1 more source

Pharmacokinetic variability of CFTR modulators from standard and alternative regimens. [PDF]

Pulm Pharmacol Ther
Rose NR, Chalamalla AR, Garcia BA, Krick S, Bergeron J, Sadeghi H, Schellhase DE, Ryan KJ, Dowell AE, Acosta EP, Guimbellot JS.   +10 more
europepmc   +1 more source

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]

J Fungi (Basel)
Chatterjee P, Moss CT, Omar S, Dhillon E, Hernandez Borges CD, Tang AC, Stevens DA, Hsu JL.   +7 more
europepmc   +1 more source

Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators. [PDF]

Pediatr Pulmonol
Yıldız CA, Selçuk Balcı M, Karabulut Ş, Başer ZM, Yüksel Kalyoncu M, Metin Çakar N, Akkitap Yiğit MM, Baysal EE, Özdemircioğlu F, Uzunoğlu B, Taştan G, Ergenekon P, Gökdemir Y, Erdem Eralp E, Karakoç F, Ata P, Karadağ B.   +16 more
europepmc   +1 more source

Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models. [PDF]

Gene Ther
McCarron A, Ling KM, Montgomery ST, Martinovich KM, Cmielewski P, Rout-Pitt N, Kicic A, Parsons D, Donnelley M.   +8 more
europepmc   +1 more source

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators. [PDF]

J Allergy Clin Immunol Glob
Mitropoulou G, Balmpouzis Z, Oberhansli-Wavre A, Morris M, Blanchon S, Sauty A, Koutsokera A.   +6 more
europepmc   +1 more source

Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators. [PDF]

Pulm Ther
Tomlinson OW, Mitchelmore P, Williams CA.   +2 more
europepmc   +1 more source

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. [PDF]

J Cyst Fibros
Jia S, Wang Y, Ross MH, Zuckerman JB, Murray S, Han MK, Cahalan SE, Lenhan BE, Best RN, Taylor-Cousar JL, Simon RH, Fitzgerald LJ, Troost JP, Sood SL, Gifford AH.   +14 more
europepmc   +1 more source